Medpace Holdings Inc 's Cash & cash equivalent grew by 40.31 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Medpace Holdings Inc 's Quick Ratio to 0.47, Quick Ratio remained below Medpace Holdings Inc average.

Within Medical Laboratories industry 24 other companies have achieved higher Quick Ratio than Medpace Holdings Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 208 to 2736.

Explain Quick Ratio?
How much Cash & cash equivalents MEDP�s has?
What are MEDP�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MEDP/financial-strength

https://api.csimarket.com/api/v1/companies/MEDP/fundamentals

https://api.csimarket.com/api/v1/companies/MEDP/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

MEDP Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	232.77 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	147.17 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.47	Subscribe	Subscribe	Subscribe	Subscribe
MEDP's Total Ranking	# 2736	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	4.23 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	40.31 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 25
Healthcare Sector	# 756
Overall Market	# 2736

Quick Ratio Statistics
High	Average	Low
2.17	0.71	0.08
(Dec 31 2021)		(Sep 30 2022)

Financial Statements
Medpace Holdings Inc 's Current Liabilities	$ 1,496 Millions	Visit MEDP's Balance sheet
Medpace Holdings Inc 's Cash & cash equivalent	$ 705 Millions	Visit MEDP's Balance sheet
Source of MEDP's Sales		Visit MEDP's Sales by Geography

Cumulative Medpace Holdings Inc 's Quick Ratio

MEDP's Quick Ratio for the trailling 12 Months

MEDP Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	135.68 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	63.44 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	0.6	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 2520	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	36.55 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	21.67 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to MEDP Financial Strength Comparisons >> Go to Compare MEDP Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2026 to $1,496.10 millions, cumulative Quick Ratio decreased to 0.6 above the MEDP average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 36 other companies have achieved higher Quick Ratio than Medpace Holdings Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 707 to 4073.

Explain Quick Ratio?
How much Cash & cash equivalents MEDP�s has?
What are MEDP�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 37
Healthcare Sector	# 904
Within the Market	#

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.77	0.3	0.04
(Dec 31 2021)		(Jun 30 2023)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Laboratories Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Radnet Inc	1.11	$ 797.880 Millions	$ 716.642 Millions
Bioaffinity Technologies Inc	1.01	$ 2.550 Millions	$ 2.533 Millions
Lumexa Imaging Holdings Inc	0.49	$ 90.011 Millions	$ 183.456 Millions
Quest Diagnostics Inc	0.49	$ 893.000 Millions	$ 1,834.000 Millions
Medpace Holdings Inc	0.47	$ 705.315 Millions	$ 1,496.097 Millions
Ge Healthcare Technologies Inc	0.32	$ 2,826.000 Millions	$ 8,815.000 Millions
Grail Inc	0.31	$ 29.394 Millions	$ 94.332 Millions
Iqvia Holdings Inc	0.31	$ 2,422.000 Millions	$ 7,777.000 Millions
Fortrea Holdings Inc	0.22	$ 220.600 Millions	$ 983.300 Millions
Charles River Laboratories International inc	0.18	$ 200.381 Millions	$ 1,089.258 Millions

Date modified: 2026-10-23T06:26:00+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.